Johnson & Johnson Announces Apple Watch Study to Improve AFib Outcomes Including Stroke Prevention

Johnson & Johnson has announced that their Janssen Pharmaceuticals company has entered into a research study with Apple to investigate whether a new heart health program used in combination with the Apple Watch can accelerate the diagnosis and improve health outcomes for people with atrial fibrillation (AFib).

The study aims to analyze the impact of Apple Watch on the early detection and diagnosis of AFib, and the potential to improve outcomes including the prevention of stroke. A multi-year research program will be launched later in 2019. This large-scale program will occur in the U.S. only, and will be designed as a pragmatic randomized controlled research study for individuals age 65 years or older.

The study's goals include:
● Measuring the outcomes of a heart health engagement program with irregular rhythm notifications on Apple Watch.
● Assessing the impact of a medication adherence program using an app from Johnson & Johnson.





Share Article:
Facebook,   Twitter,   LinkedIn,   Google Plus,   Email,   Reddit,   Digg,   Delicious,   StumbleUpon

Follow iClarified:
Facebook,   Twitter,   LinkedIn,   Google Plus,   Newsletter,   App Store,   YouTube

Advertise Here